loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 204910 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 DR REDDYS (3)

filter

01 SOLUTION;INTRAVENOUS (3)

filter

01 RX (3)

filter

01 PARICALCITOL (3)

filter

01 No (3)

URL Supplier Web Content
SOLUTION; INTRAVEN...
0.01MG/2ML (0.005M...
2016-08-17
204910
PARICALCITOL
RX
No
AP
URL Supplier Web Content
SOLUTION; INTRAVEN...
0.002MG/ML (0.002M...
2016-08-17
204910
PARICALCITOL
RX
No
AP
URL Supplier Web Content
SOLUTION; INTRAVEN...
0.005MG/ML (0.005M...
2016-08-17
204910
PARICALCITOL
RX
No
AP

Looking for FDA Orange Book APPLICATION 204910

Looking for FDA Orange Book APPLICATION 204910 3

19

Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

One of their notable products is PARICALCITOL, with a corresponding application number 204910.

Regulatory Information RX

With a dosage strength 0.01MG/2ML (0.005MG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug No

Approved since 2016-08-17

Therapeutic Equivalence (TE) Code AP

18

Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

One of their notable products is PARICALCITOL, with a corresponding application number 204910.

Regulatory Information RX

With a dosage strength 0.002MG/ML (0.002MG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug No

Approved since 2016-08-17

Therapeutic Equivalence (TE) Code AP

17

Dr. Reddy\'s Laboratories, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

They are recognized for DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

One of their notable products is PARICALCITOL, with a corresponding application number 204910.

Regulatory Information RX

With a dosage strength 0.005MG/ML (0.005MG/ML)

Dosage Form Route SOLUTION; INTRAVENOUS

Reference Listed Drug No

Approved since 2016-08-17

Therapeutic Equivalence (TE) Code AP

Post Enquiry
POST ENQUIRY